Filter
124
Text search:
delamanid
Featured
Recommendations
23
New Publications
33
Language
Document type
No document type
78
Guidelines
18
Studies & Reports
12
Manuals
7
Fact sheets
3
Training Material
2
Situation Updates
2
Infographics
1
Strategic & Response Plan
1
Countries / Regions
Western and Central Europe
14
Eastern Europe
11
Germany
4
India
2
South Africa
2
Namibia
2
Bolivia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Russia
2
Global
2
Ethiopia
1
Zambia
1
Turkey
1
Malawi
1
Botswana
1
Latin America and the Carribbean
1
Paraguay
1
Tajikistan
1
Estonia
1
Romania
1
Georgia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
32
Countries
18
Pharmacy & Technologies
3
Public Health
1
Key Resources
1
Toolboxes
TB
106
HIV
4
Pharmacy
3
Caregiver
2
NTDs
2
Ebola & Marburg
1
Polio
1
Refugee
1
Global Health Education
1
AMR
1
COVID-19
1
Health Financing Toolbox
1
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Tuberculosis Guideline for Adults
Guideline for Diagnosis
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
A survival guide for clinicans.
3rd edition.
Policy framework.
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon
...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu
...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
Towards ending tuberculosis and multidrug-resistant tuberculosis.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
